Teva Pharmaceuticals Terazosin Hydrochloride Capsules Recall

Why it was recalled

Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules

Product description

Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-4339-01

Lot numbers, UPCs & expiration codes

Lot # N07321, Exp 6/14

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-842-2013
Classification: Class II
Status: Terminated
Recall initiated: Jul 23, 2013
FDA report date: Aug 14, 2013
Quantity: 6267 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-842-2013, exactly as published.

Show all FDA fields

City: Sellersville
State: PA
Status: Terminated
Country: United States
Event ID: 65826
Address: 650 Cathill Rd
Code information: Lot # N07321, Exp 6/14
Postal code: 18960-1512
Report date: Aug 14, 2013
Product type: Drugs
Recall number: D-842-2013
Classification: Class II
Recalling firm: Teva Pharmaceuticals USA, Inc.
Product quantity: 6267 bottles
Termination date: Aug 27, 2014
Reason for recall: Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules
Voluntary / mandated: Voluntary: Firm initiated
Product description: Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-4339-01
Distribution pattern: Nationwide and Puerto Rico
Recall initiation date: Jul 23, 2013
Initial firm notification: Letter
Center classification date: Aug 6, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-842-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.